The SMISS '10 Highlights Series: Scientific Abstracts: MIS Strategies for Low Back Pain, and the Pre-sacral Technique

Agenda

Free Paper #19: Biomechanical Evaluation of a Standalone Lumbar Interbody Cage with Integrated Screws
Frank M. Phillips, MD

Free Paper #20: A Comparison of MIS Fusion to Open Fusion for Degenerative Lumbar Disorders: A Systematic Review
Raja Rampersaud, MD, FRCS

Free Paper #22: The Efficacy of Silicated Calcium Phosphate Bone Graft Substitute (Actifuse) in Minimally invasive Lumbar Interbody Fusion Procedures
Vamsi V. Nagineni, MD

Free Paper #23: Safety and Complications of Profile of Percutaneous Lumbosacral Axial Interbody Fusion
Neel Anand, MD

Free Paper #24: Axial Interbody Fusion (AxiaLIF) Patients Show Negligible Postsurgical Complications: Analysis of First 70 Consecutive Cases
Atiq Durrani, MD

Media

Internet

Release Date: March 25, 2011
Expiration Date: March 24, 2012

Faculty

  • Neel Anand, MD About

    Director, Orthopaedic Spine Surgery
    Minimally Invasive Spine Surgery
    Director, Orthopaedic and Nuerosurgery Spine Fellowship

    Spine Center, Cedars Sinai Medical Center
    Beverly Hills, CA USA

    Doctor Neel Anand is the Director of Orthopaedic Spine Surgery at the Cedars-Sinai Institute for Spinal Disorders in Los Angeles, California. He is certified by the Royal College of Surgeons in England and American Board of Orthopaedic Surgery.  Read More

  • Attiq A. Durrani, MD About

    Orthopaedic Spine Surgeon 

    Center for Advanced Spine Technologies
    Cincinnati, OH USA 

     

  • Vamsi V. Nagineni, MD
  • Frank Phillips, MD
  • Y. Raja Rampersaud, MD, FRCS(c) About

    Toronto Western Hospital
    Toronto, ON Canada

     

Target Audience

This online continuing educational program has been designed to meet the educational needs of orthopaedic and neurological surgeons, and their fellows and residents, and other specialties involved in the care of patients with spinal disorders.

Educational Objectives

At the conclusion of the program, participants will be able to:

  • Describe the outcomes and complications reported in two studies of the lumbosacral axial fusion technique.
  • Discuss the results of various studies into the efficacy of various MISS techniques and technologies.

Statement of Educational Needs

The field of minimally invasive spine surgery (MISS) has expanded dramatically in the last 5 years. MISS techniques are now utilized to treat all types of spinal disorders. Spine surgeons attempt to keep up with MISS advances in an environment in which several major peer-reviewed journals publish more than 50 new articles monthly, and in which new MISS techniques and technologies are consistently emerging. In the midst of this, it is very challenging for spine surgeons to be aware of what is the current standard of care for spine patients treated with MISS techniques.

In this context, there is a need for spine surgeons to have access to concise updates on research into MISS that have been identified by peer review as being of significant clinical and scientific value.

Course Completion Time

Based upon trials, the estimated time to complete this program is 0.5 hour.

Sponsorship

This activity is jointly sponsored by Medical Education Resources, Inc., and BroadWater, LLC.

You can review the MER Privacy Policy.
Or you can contact MER.

Educational Grant

This activity is supported by an educational grant from: SMISS (www.smiss.org) is a non-profit, charitable organization devoted to improving the health of patients with spinal disorders by advancing the highest quality minimally invasive spinal care for patients.

Physician Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medical Education Resources, Onc. (MER) and BroadWater, LLC. Medical Education Resources is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Medical Education Resources designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in health care and not the business interest of a commercial interest.

Faculty Disclosure

In accordance with U.S. Food and Drug Administration (FDA) and ACCME guidelines, the financial and significant relationships to this program are listed below.

Neel Anand, MD has indicated the following relevant financial relationships: Stock or stock option held in: TranS1, Globus, Co-Align; Consultant or employee: Medtronic, TranS1, Globus, Co-Align

Attiq A. Durrani, MD has indicated no relevant financial relationships to disclose.

Vamsi V. Nagineni, MD has indicated no relevant financial relationships to disclose.

Frank Phillips, MD has indicated the following relevant financial relationships: Stock/Shareholder: NuVasive, Baxano, Flexuspine, Spinal Motion, Spinal Kinetics, Crosstrees, AxioMet; Royalties: NuVasive, DePuy.

Y. Raja Rampersaud, MD, FRCS(c) has indicated the following relevant financial relationships: Stock or stock option held in Medtronic; Consultant or employee: Medtronic

Staff Disclosure

In accordance with U.S. Food and Drug Administration (FDA) and ACCME requirements, the relevant financial and significant relationships of staff/content advisors who have been involved with this program are disclosed below:

Jeremy Longhurst
No items to disclose.

Julie Gentile
No items to disclose.

Nathan Scott (MER)
No items to disclose.

Method of Participation

There are no fees for participating in and receiving CME credit for this activity. During the period March 25, 2011, through March 24, 2012, participants must:

  1. read the learning objectives and faculty disclosures,
  2. study the educational activity,
  3. complete the posttest,
  4. complete the evaluation form, and
  5. submit the completed post test and evaluation form via www.SpineCME.org Participants will be able to obtain their statement of credit upon online submission of the completed posttest and evaluation with a score of 80% or better.

Disclaimer

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of MER or BroadWater, LLC. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MER or BroadWater, LLC.

Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Purpose

This program is for educational and scientific purposes only. Any discussion of a product will be objective, balanced, and scientifically rigorous.

Off-Label/Investigational Use

It should be noted that specific medicines and medical devices discussed or referred to in this program may not yet be specifically cleared by the FDA for use in the United States. It is emphasized that package inserts must be referred to for labeling limitations for products used in the United States.

Software Requirements